| Literature DB >> 27296395 |
Mohammad Shoaib1, Syed Wadood Ali Shah2, Niaz Ali3, Ismail Shah2, Shafi Ullah2, Mehreen Ghias2, Muhammad Nawaz Tahir4, Farah Gul5, Sohail Akhtar6, Abd Ullah2, Wajid Akbar2, Asad Ullah2.
Abstract
BACKGROUND: Tissue damage is associated with pain, which is an alarming sign. Aspirin and morphine have been widely used in recent decades for management of pain. Medicinal herbs have been in use for treatment of different diseases for centuries. Many of these herbs possess analgesic activity with relatively less incidences of adverse effects. The strong positive correlation of alkaloids in medicinal plants for analgesic activity persuades an intention to determine possible analgesic activity of total alkaloids extracted from the selected medicinal plants using animal models to answer its possible mechanisms.Entities:
Keywords: Crude alkaloids; Naloxone; Opioid; Pain; Peganum harmala; Traditional uses; Woodfordia fruticosa
Mesh:
Substances:
Year: 2016 PMID: 27296395 PMCID: PMC4906632 DOI: 10.1186/s12906-016-1157-2
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Fig. 1Analgesic activity of crude alkaloids using acetic acid induced writhing model. All the values are expressed as mean ± SEM (n = 6). * P < 0.05, ** P < 0.01, *** P < 0.001 when compared to control group
Effects of crude alkaloids and standardson formalin-induced paw-licking response in mice
| Treatment/Dose | Licking time (Sec) | Inhibition (%) | ||
|---|---|---|---|---|
| 1st Phase | 2nd Phase | 1st Phase | 2nd Phase | |
| Control (2 % Tween 80) | 48.83 ± 1.627 | 72.83 ± 1.287 | ---- | ---- |
| Wf Cr.A 50 mg | 22.35 ± 1.231*** | 20.12 ± 1.163*** | 54.22 | 72.37 |
| Av Cr.A 50 mg | 28.31 ± 1.347** | 31.45 ± 1.342*** | 42.14 | 56.81 |
| Ca Cr.A 50 mg | 34.75 ± 1.441* | 44.39 ± 1.568* | 28.68 | 39.04 |
| Vn Cr.A 50 mg | 33.35 ± 1.604* | 38.93 ± 1.195** | 31.82 | 46.54 |
| Ph Cr.A 50 mg | 24.85 ± 1.289*** | 24.53 ± 1.391*** | 49.16 | 66.31 |
| Bp Cr.A 50 mg | 27.80 ± 1.468** | 33.79 ± 1.416** | 43.09 | 53.60 |
| Indomethacin (10 mg) | 39.83 ± 1.541 | 18.66 ± 1.542*** | 18.43 | 74.37 |
| Morphine (5 mg) | 6.416 ± 1.165*** | 2.83 ± 1.260*** | 86.86 | 96.11 |
All the values are expressed as mean ± SEM. * P < 0.05, ** P < 0.01 and *** P < 0.001 when compared to control group (one way ANOVA followed by Dunnetts: compare all vs control test)
Fig. 2a Analgesic effect of extracted crude alkaloids on formalin induced licking response in first phase of the test. Values are mean ± SEM, n = 6, * P < 0.05, ** P < 0.01, *** P < 0.001 significantly different compared with control. b: Analgesic effect of extracted crude alkaloids on formalin induced licking response in second phase of the test. Values are mean ± SEM, n = 6, * P < 0.05, ** P < 0.01, *** P < 0.001 significantly different compared with control
Analgesic effects of crude alkaloids and standard drugs using tail flick method
| Time in Sec (Tail Flick)/Response (%) | ||||||
|---|---|---|---|---|---|---|
| Treatment/Dose | 15 min | 30 min | 45 min | 60 min | 75 min | 90 min |
| Control (2 % Tween 80) | 0.78 ± 1.30 | 0.88 ± 1.21 | 0.98 ± 1.021 | 0.93 ± 1.381 | 0.86 ± 1.025 | 0.92 ± 1.401 |
| Wf Cr.A 50 mg | 1.01 ± 1.12* (22.70 %) | 1.38 ± 1.112* (36.23 %) | 1.68 ± 1.131** (41.66 %) | 2.13 ± 1.124** (56.33 %) | 2.41 ± 1.163*** (64.31 %) | 2.15 ± 1.138*** (57.20 %) |
| Av Cr.A 50 mg | 0.92 ± 1.20 (15.21 %) | 1.14 ± 1.411* (22.52 %) | 1.41 ± 1.161** (30.49 %) | 1.48 ± 1.201** (37.16 %) | 1.65 ± 1.206*** (47.87 %) | 1.57 ± 1.282*** (41.40 %) |
| Ca Cr.A 50 mg | 0.89 ± 1.30 (12.35 %) | 1.09 ± 1.411* (19.85 %) | 1.35 ± 1.161** (27.40 %) | 1.39 ± 1.231** (33.09 %) | 1.53 ± 1.226*** (43.79 %) | 1.49 ± 1.218*** (38.25 %) |
| Vn Cr.A 50 mg | 0.90 ± 1.10 (13.81 %) | 1.12 ± 1.521* (21.75 %) | 1.38 ± 1.611** (28.98 %) | 1.40 ± 1.421** (33.80 %) | 1.55 ± 1.261*** (44.69 %) | 1.51 ± 1.618*** (39.27 %) |
| Ph Cr.A 50 mg | 0.97 ± 0.82 (19.58 %)* | 1.23 ± 1.135* (28.45 %) | 1.70 ± 1.141** (42.35 %) | 2.08 ± 1.511** (55.28 %) | 2.33 ± 1.133** (63.09 %) | 2.04 ± 1.123** (54.90 %) |
| Bp Cr.A 50 mg | 0.90 ± 0.97 (13.81 %) | 1.11 ± 1.411* (20.42 %) | 1.37 ± 1.261** (28.46 %) | 1.42 ± 1.301** (34.50 %) | 1.57 ± 1.237*** (45.22 %) | 1.53 ± 1.218*** (39.90 %) |
| Standard (Morphine 5 mg) | 1.54 ± 1.24** (49.35 %) | 2.11 ± 1.066** (58.29 %) | 4.52 ± 1.038*** (78.31 %) | 6.12 ± 1.054*** (84.80 %) | 4.98 ± 1.309*** (82.70 %) | 4.74 ± 1.074*** (80.59 %) |
| Wf Cr.A (50 mg) + Naloxone (2 mg) | 0.82 ± 0.83 | 0.81 ± 1.165 | 0.93 ± 1.049 | 0.99 ± 1.308 | 0.87 ± 1.029 | 0.83 ± 1.461 |
| Av Cr.A (50 mg) + Naloxone (2 mg) | 0.96 ± 0.91 | 0.86 ± 1.036 | 0.88 ± 1.131 | 0.94 ± 1.047 | 0.89 ± 1.381 | 0.84 ± 1.069 |
| Ca Cr.A (50 mg) + Naloxone (2 mg) | 0.84 ± 1.08 | 0.91 ± 1.044 | 0.84 ± 1.045 | 0.89 ± 1.642 | 0.94 ± 1.263 | 0.78 ± 1.422 |
| Vn Cr.A (50 mg) + Naloxone (2 mg) | 0.94 ± 1.03 | 0.88 ± 1.051 | 0.81 ± 1.521 | 0.83 ± 1.342 | 0.86 ± 1.061 | 0.87 ± 1.356 |
| Ph Cr.A (50 mg) + Naloxone (2 mg) | 0.81 ± 0.69 | 0.96 ± 1.031 | 1.05 ± 1.271 | 0.97 ± 1.535 | 0.91 ± 1.251 | 0.93 ± 1.034 |
| Bp Cr.A 50 mg + Naloxone (2 mg) | 0.88 ± 1.124 | 0.81 ± 0.89 | 0.94 ± 1.034 | 0.86 ± 1.324 | 0.93 ± 1.304 | 0.94 ± 1.263 |
| Morphine (5 mg) + Naloxone (2 mg) | 0.76 ± 0.82 | 0.87 ± 1.336 | 0.96 ± 1.204 | 0.95 ± 1.641 | 0.89 ± 1.035 | 0.97 ± 1.432 |
All the values were expressed as mean ± SEM. * P < 0.05, ** P < 0.01 and *** P < 0.001 when compared to control group (one way ANOVA followed by Dunnetts: compare all vs control test)